Skip to content

MBIO

Mustang Bio, Inc.

NASDAQ · Healthcare · Biotechnology · US

$0.54
−3.88%
Ask drillr

Income statement

MetricTTM2025202420232022
Revenue
Total Revenue
Cost of Revenue41.0K2.2M3.0M
Gross Profit(41.0K)(2.2M)(3.0M)
Operating Expenses
R&D Expense418.0K1.5M8.4M39.2M63.9M
SG&A Expense3.8M3.9M4.1M9.3M12.2M
General & Admin Expense3.8M3.9M4.1M9.7M12.2M
Selling & Marketing Expense(365.0K)
Other Expenses(666.0K)(3.1M)3.7M(3.0M)
Total Operating Expenses3.5M2.4M16.2M48.5M73.1M
Cost and Expenses3.5M2.4M16.2M50.7M76.2M
Operating Income (EBIT)(3.5M)(2.4M)(16.2M)(50.7M)(76.2M)
Non-Operating
Interest Income489.0K511.0K184.0K850.0K689.0K
Interest Expense(5.0K)1.3M3.4M
Net Interest Income489.0K511.0K189.0K(464.0K)(2.7M)
Other Non-Op Income/Expense489.0K511.0K493.0K(876.0K)(1.4M)
Non-Operating Income (excl Interest)(489.0K)(511.0K)(498.0K)(438.0K)(2.0M)
EBT (Pre-Tax Income)(3.0M)(1.9M)(15.8M)(51.6M)(77.5M)
Income Tax Expense
Bottom Line
Net Income(3.0M)(1.9M)(15.8M)(51.6M)(77.5M)
Earnings from Cont. Ops(3.0M)(1.9M)(15.8M)(51.6M)(77.5M)
Earnings from Discont. Ops
Bottom Line Net Income(3.0M)(1.9M)(15.8M)(51.6M)(77.5M)
Per Share
Basic EPS($0.45)($0.39)($2.57)($6.00)($11.25)
Diluted EPS($0.45)($0.39)($2.57)($6.00)($11.25)
Revenue Per Share$0.00$0.00$0.00$0.00$0.00
Shares
Basic Shares Outstanding6.7M4.9M6.1M8.6M6.9M
Diluted Shares Outstanding6.7M4.9M6.1M8.6M6.9M
Profitability Metrics
EBITDA(3.0M)(1.9M)(14.9M)(48.1M)(71.1M)
D&A41.0K823.0K2.2M3.0M
EBIT(3.0M)(1.9M)(15.7M)(50.3M)(74.2M)

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026